Clinical Trials Directory

Trials / Completed

CompletedNCT00502047

Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia

Multicentre, Comparative, Double-Blind, Two-Arm Parallel Clinical Trial of the Effects of Treatment With Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
255 (actual)
Sponsor
Rottapharm Spain · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of this study is that soluble fibre may contribute to a reduction of the low density lipoprotein cholesterol (LDL-c), and the combined effect with a statin may achieve an optimisation of the cholesterol-lowering effects in adults with several cardiovascular risk factors.

Detailed description

It has been demonstrated that high concentrations of cholesterol and low density lipoprotein cholesterol (LDL, high risk cholesterol) are the major risk factors for heart disease, myocardial infarction and angina pectoris. Moreover, these conditions represent the major cause of death in the Western world. Of the measures established to reduce blood cholesterol levels, the introduction of consumption of dietary fibre is a novelty. The term dietary fibre defines a variety of substances that are found in plants and are resistant to digestion by human gastrointestinal enzymes. The studies performed up until now to determine the effects of fibre on blood lipids have demonstrated that consumption of soluble fibre can reduce cholesterol.

Conditions

Interventions

TypeNameDescription
DRUGPlantago ovata husk

Timeline

Start date
2005-09-01
Completion
2007-07-01
First posted
2007-07-17
Last updated
2007-07-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00502047. Inclusion in this directory is not an endorsement.